These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 4257821)
1. [Cholestatic hepatosis induced by diphenylhydantoin]. Martin W; Rickers J Wien Klin Wochenschr; 1972 Jan; 84(3):41-5. PubMed ID: 4257821 [No Abstract] [Full Text] [Related]
2. Diphenylhydantoin sensitivity. a syndrome resembling infectious mononucleosis with a morbilliform rash and cholestatic hepatitis. Weedon AP Aust N Z J Med; 1975 Dec; 5(6):561-3. PubMed ID: 132924 [TBL] [Abstract][Full Text] [Related]
3. [Toxic cholestatic hepatitis due to phenytoin]. de la Serna Higuera C; Gil Grande LA; Bárcena Marugán R Gastroenterol Hepatol; 1995 Nov; 18(9):471-3. PubMed ID: 8521225 [TBL] [Abstract][Full Text] [Related]
4. [The histo-morphologic patterns of cholestatic hepatosis (author's transl)]. Godzinski M; Hackl H Med Klin; 1977 Jul; 72(30):1252-6. PubMed ID: 887052 [TBL] [Abstract][Full Text] [Related]
5. Phenytoin-induced toxic cholestatic hepatitis in a patient with skin lesions: case report. Altuntaş Y; Oztürk B; Erdem L; Günes G; Karul S; Uçak S; Sengül A South Med J; 2003 Feb; 96(2):201-3. PubMed ID: 12630649 [TBL] [Abstract][Full Text] [Related]
6. Phenytoin hypersensitivity hepatitis and mononucleosis syndrome. Brown M; Schubert T J Clin Gastroenterol; 1986 Aug; 8(4):469-77. PubMed ID: 3093562 [TBL] [Abstract][Full Text] [Related]
8. Diphenylhydantoin-induced hepatitis: a case report. Gloria L; Serejo F; Cruz E; Freitas J; Costa A; Ramalho F; Batista A; de Moura MC Hepatogastroenterology; 1998; 45(20):411-4. PubMed ID: 9638415 [TBL] [Abstract][Full Text] [Related]
9. Skin eruption and cholestatic hepatic injury due to vismodegib. Drago F; Trave I; Wei Y; Parodi A G Ital Dermatol Venereol; 2019 Aug; 154(4):496-497. PubMed ID: 29199802 [No Abstract] [Full Text] [Related]
10. Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases. Mullick FG; Ishak KG Am J Clin Pathol; 1980 Oct; 74(4):442-52. PubMed ID: 7424826 [TBL] [Abstract][Full Text] [Related]
11. Mononucleosis and hepatic failure associated with diphenylhydantoin treatment in an infant. Ni YH; Chang MH; Wu MZ J Formos Med Assoc; 1991 Feb; 90(2):202-5. PubMed ID: 1678417 [TBL] [Abstract][Full Text] [Related]
12. Cholestatic liver dysfunction after long-term phenytoin therapy. Taylor JW; Stein MN; Murphy MJ; Mitros FA Arch Neurol; 1984 May; 41(5):500-1. PubMed ID: 6721716 [TBL] [Abstract][Full Text] [Related]
13. Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism. Campbell CB; McGuffie C; Weedon AP; Powell LW Am J Dig Dis; 1977 Mar; 22(3):255-62. PubMed ID: 842535 [TBL] [Abstract][Full Text] [Related]
14. [Cholestatic hepatosis and ovulation inhibitors]. Dirschmid K; Felkel W; Temesrekasi K Med Klin; 1971 Sep; 66(38):1264-8. PubMed ID: 5110342 [No Abstract] [Full Text] [Related]
18. Cholestatic hepatitis after administration of furan derivatives. Engel JJ; Vogt TR; Wilson DE Arch Intern Med; 1975 May; 135(5):733-5. PubMed ID: 150825 [TBL] [Abstract][Full Text] [Related]
19. [Pseudomononucleosis induced by diphenylhydantoin (author's transl)]. Rodriguez Jornet A; Matías-Guiu J; Coll de Tuero G; Villegas Sánchez G; Sánchez Novials A; Sabriá Leal M Med Clin (Barc); 1981 Oct; 77(6):250-2. PubMed ID: 7321640 [TBL] [Abstract][Full Text] [Related]
20. Bupivacaine drug-induced liver injury: a case series and brief review of the literature. Chintamaneni P; Stevenson HL; Malik SM J Clin Anesth; 2016 Aug; 32():137-41. PubMed ID: 27290962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]